2026-02-24
Grip Strength as a Longevity Biomarker: What It Predicts and How to Maintain It
Grip strength is a validated predictor of all-cause mortality, cardiovascular outcomes, and functional decline. This review covers the evidence base, what thresholds matter, and practical strategies to maintain grip and overall muscular capacity with age.
2026-02-24
Orthostatic Intolerance in Aging: Causes, Risks, and Evidence-Based Management
Orthostatic intolerance — dizziness or near-fainting upon standing — affects up to 20% of adults over 65 and substantially increases fall risk. This article reviews the mechanisms and evidence-based management strategies.
2026-02-24
Social Isolation and Loneliness in Aging: The Hidden Health Crisis
Loneliness and social isolation are among the strongest independent predictors of cardiovascular disease, cognitive decline, and early mortality in older adults. This article reviews the evidence and practical mitigation strategies.
2026-02-24
Testosterone Decline in Aging Men: Natural Interventions, Monitoring, and TRT Context
Testosterone declines ~1% per year after age 30 in men. Below clinical thresholds, symptoms include fatigue, sarcopenia, and cognitive fog. Lifestyle interventions (resistance training, sleep, zinc, vitamin D) have the best evidence for supporting endogenous production. Ashwagandha and fenugreek show modest RCT data.
2026-02-23
Blood Sugar and Insulin Resistance: Supplement Protocol, Monitoring, and Evidence Summary
Insulin resistance precedes type 2 diabetes by years and independently drives cardiovascular risk, cognitive decline, and accelerated aging. Berberine, magnesium, alpha-lipoic acid, and chromium have the best evidence among supplements. This protocol integrates the strongest interventions with clear monitoring markers.